Paper Details

  1. Home
  2. Paper Details

Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.

Author: , BresslerNeil M, RubinGary S

Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study examined the effects of verteporfin therapy on contrast sensitivity (the ability to see differences in shades) in patients with age-related macular degeneration (AMD) who had abnormal blood vessel growth (choroidal neovascularization, CNV) under the macula. The study found that verteporfin therapy, a type of photodynamic therapy, reduced the risk of significant vision loss (at least 15 letters of vision acuity) in these patients. The study further analyzed contrast sensitivity outcomes in these patients over two years.
Paper Details　
Original Abstract of the Article :
In the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation, verteporfin therapy reduced the risk of at least moderate vision loss (defined as a loss of at least 15 letters of visual acuity) in patients with subfoveal choroidal neovascularization (CNV) secondar...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/00006982-200210000-00002

データ提供：米国国立医学図書館（NLM）

Verteporfin Therapy: Preserving Vision in Age-Related Macular Degeneration

This study explores the impact of verteporfin therapy on contrast sensitivity in patients with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (ARMD). The researchers investigated the long-term effects of verteporfin therapy on vision loss in a large clinical trial.

The study revealed a significant benefit of verteporfin therapy in preserving vision in patients with ARMD-related CNV. The researchers observed a reduced risk of at least moderate vision loss in patients receiving verteporfin therapy. The study provides valuable insights into the effectiveness of verteporfin therapy in managing ARMD-related CNV and preserving visual function in affected patients.

Protecting Vision: A New Hope for ARMD Patients

The study's findings offer hope for patients with ARMD-related CNV, demonstrating the potential of verteporfin therapy to preserve vision and prevent further vision loss. This study encourages further research into the mechanisms of verteporfin therapy and its long-term effects on visual function in ARMD patients.

Understanding Age-Related Macular Degeneration: A Complex Condition

The study highlights the complexity of ARMD, a leading cause of vision loss in older adults. The researchers' investigation of verteporfin therapy provides valuable insights into the mechanisms underlying this condition and the potential for effective treatment. The study emphasizes the importance of early detection and timely intervention for ARMD, potentially preserving vision and improving the quality of life for affected individuals.

Dr.Camel's Conclusion

Imagine a vast desert, where the sands of time are constantly shifting, and the landscape can change in an instant. This study is like a compass guiding us through the complex world of ARMD, revealing the potential of verteporfin therapy to preserve vision in patients with this debilitating condition. The researchers' findings provide hope for a future where ARMD-related vision loss can be effectively managed, allowing individuals to maintain their independence and quality of life. The study is a testament to the power of scientific discovery and the dedication of researchers in finding solutions to complex medical challenges.

Date :
  1. Date Completed 2003-01-06
  2. Date Revised 2019-09-06
Further Info :

Pubmed ID

12441717

DOI: Digital Object Identifier

10.1097/00006982-200210000-00002

Related Literature

Article Analysis
・Effective treatment of macular degeneration
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.